American College of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics (ACMG). (2001). Preconception and prenatal carrier screening for cystic fibrosis. Washington, DC: Author.
Berkenstadt, M., Ries-Levavi, L., Cuckle, H., Peleg, L., & Barkai, G. (2007). Preconceptional and prenatal screening for fragile X syndrome: Experience with 40,000 tests. [Evaluation studies]. Prenatal Diagnosis, 27, 991–994.
Cao, A., Pintus, L., Lecca, U., Olla, G., Cossu, P., Rosatelli, C., & Galanello, R. (1984). Control of homozygous beta-thalassemia by carrier screening and antenatal diagnosis in Sardinians. Clinical Genetics, 26, 12–22.
Cao, A., Saba, L., Galanello, R., & Rosatelli, M. C. (1997). Molecular diagnosis and carrier screening for beta thalassemia. Journal of the American Medical Association, 278, 1273–1277.
Castellani, C., Picci, L., Tamanini, A., Girardi, P., Rizzotti, P., & Assael, B. M. (2009). Association between carrier screening and incidence of cystic fibrosis. JAMA, 302, 2573–2579.
Cousens, N. E., Gaff, C. L., Metcalfe, S. A., & Delatycki, M. B. (2010). Carrier screening for beta-thalassaemia: A review of international practice. European Journal of Human Genetics, 18, 1077–1083.
Delatycki, M. B. (2008). Population screening for reproductive risk for single gene disorders in Australia: Now and the future. Twin Research and Human Genetics, 11, 422–430.
Delatycki, M., Allen, K., & Williamson, R. (2002). Insurance agreement to facilitate genetic testing. Lancet, 359, 1433.
Hale, J. E., Parad, R. B., & Comeau, A. M. (2008). Newborn screening showing decreasing incidence of cystic fibrosis. New England Journal of Medicine, 358, 973–974.
Harris, H., Scotcher, D., Hartley, N., Wallace, A., Craufurd, D., & Harris, R. (1996). Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice. British Journal of General Practice, 46, 225–227.
Hausen, J. (2012, February 26). Gardiner couple sues medical providers in wrongful birth case. Bozeman Daily Chronicle.
Ioannou, L., Massie, J., Lewis, S., Petrou, V., Gason, A., Metcalfe, S., . . . Delatycki, M. B. (2010). Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools. Clinical Genetics, 78, 21–31.
Kaback, M. M., Nathan, T., & Greenwald, S. (1997). Tay-Sachs disease: Heterozygote screening and prenatal diagnosis. US experience and world perspective. In Kaback, M. M. (Ed.), Tay-Sachs disease, screening and prevention (pp. 13–36). New York: Alan R Liss.
Levenson, D. (2010). New test could make carrier screening more accessible. American Journal of Medical Genetics Part A, 152A (4), vii–viii.
Locock, L., & Kai, J. (2008). Parents’ experiences of universal screening for haemoglobin disorders: Implications for practice in a new genetics era. British Journal of General Practice, 58, 161–168.
Massie, J., Petrou, V., Forbes, R., Curnow, L., Ioannou, L., Dusart, D., . . .Delatycki, M. (2009). Population-based carrier screening for cystic fibrosis in Victoria: The first three years experience. Australian and New Zealand Journal of Obstetrics and Gynaecology, 49, 484–489.
McClaren, B. J., Metcalfe, S. A., Aitken, M., Massie, R. J., Ukoumunne, O. C., & Amor, D. J. (2010). Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening. European Journal of Human Genetics, 18, 1084–1089.
McClaren, B. J., Metcalfe, S. A., Amor, D. J., Aitken, M., & Massie, J. (2011). A case for cystic fibrosis carrier testing in the general population. Medical Journal of Australia, 194, 208–209.
Mennie, M. E., Gilfillan, A., Compton, M., Curtis, L., Liston, W. A., Pullen, I., . . . Brock, D. J. (1992). Prenatal screening for cystic fibrosis. Lancet, 340, 214–216.
Metcalfe, S., Jacques, A., Archibald, A., Burgess, T., Collins, V., Henry, A., . . . Cohen, J. (2008). A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study. Genetics in Medicine, 10, 525–535.
Modell, B., & Mouzouras, M. (1982). Social consequences of introducing antenatal diagnosis for thalassemia. Birth Defects Original Article Series, 18, 285–291.
Modra, L. J., Massie, R. J., & Delatycki, M. B. (2010). Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening. Medical Journal of Australia, 193, 157–160.
Morgan, M. A., Driscoll, D. A., Mennuti, M. T., & Schulkin, J. (2004). Practice patterns of obstetrician-gynecologists regarding preconception and prenatal screening for cystic fibrosis. Genetics in Medicine, 6, 450–455.
Morgan, M. A., Driscoll, D. A., Zinberg, S., Schulkin, J., & Mennuti, M. T. (2005). Impact of self-reported familiarity with guidelines for cystic fibrosis carrier screening. Obstetrics & Gynecology, 105, 1355–1361.
Scriver, C. R., Bardanis, M., Cartier, L., Clow, C. L., Lancaster, G. A., & Ostrowsky, J. T. (1984). Beta-thalassemia disease prevention: Genetic medicine applied. American Journal of Human Genetics, 36, 1024–1038.
Su, Y. N., Hung, C. C., Lin, S. Y., Chen, F. Y., Chern, J. P., Tsai, C., . . . Lee, C. N. (2011). Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: A prospective population-based cohort study. PloS One, 6, e17067.
Sugarman, E. A., Nagan, N., Zhu, H., Akmaev, V. R., Zhou, Z., Rohlfs, E. M., . . . Allitto, B. A. (2012). Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: Clinical laboratory analysis of >72,400 specimens. European Journal of Human Genetics, 20, 27–32.
Wald, N. J., George, L. M., Wald, N. M., & Mackenzie, I. (1993). Couple screening for cystic fibrosis. Lancet, 342, 1307–1308.
Wilkins-Haug, L., Hill, L., Schmidt, L., Holzman, G. B., & Schulkin, J. (1999). Genetics in obstetricians’ offices: A survey study. Obstetrics & Gynecology, 93, 642–647.
Zeesman, S., Clow, C. L., Cartier, L., & Scriver, C. R. (1984). A private view of heterozygosity: Eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. American Journal of Human Genetics, 18, 769–778.